Precision medicine for drug-resistant tuberculosis in high-burden countries: is individualised treatment desirable and feasible? (2018)
Attributed to:
Optimizing health systems to improve delivery of decentralized care for patients with drug resistant tuberculosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(18)30104-x
PubMed Identifier: 29548923
Publication URI: http://europepmc.org/abstract/MED/29548923
Type: Journal Article/Review
Volume: 18
Parent Publication: The Lancet. Infectious diseases
Issue: 9
ISSN: 1473-3099